Northpond Ventures, LLC
- SEC CIK
- 0001911245
- Latest filing
- Nov 14, 2024
Holdings in Q3 2024
Holdings as of Sep 30, 2024, filed Nov 14, 2024. Long positions only; changes compare share counts with Q2 2024.
- Positions
- 3
- −1 vs. Q2 2024
- Portfolio value
- $43.7M
- −$11.6M (−21.0%) vs. Q2 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| KYTXKyverna Therapeutics, Inc. | COM | 3,255,426 | $15.9M | 36.5% | 00.0% | Unchanged | History |
| VIGLVigil Neuroscience, Inc. | COM | 4,214,498 | $14.3M | 32.8% | 00.0% | Unchanged | History |
| CADLCandel Therapeutics, Inc. | COM | 1,935,215 | $13.4M | 30.7% | 00.0% | Unchanged | History |
Sold out since Q2 2024 (1)
Positions held at the end of Q2 2024 that are gone from this filing.